Patents Assigned to Therakind Ltd.
  • Methotrexate formulation
    Patent number: 11771701
    Abstract: A liquid pharmaceutical composition comprises methotrexate free acid and a buffer, wherein the pH of the composition is in the range of 6.5 to 8.2. Processes for preparation of the liquid pharmaceutical composition are also described. The liquid pharmaceutical composition is useful in therapy.
    Type: Grant
    Filed: August 26, 2021
    Date of Patent: October 3, 2023
    Assignee: Therakind Ltd.
    Inventors: Michael Frodsham, Julie-Ann Penton
  • Methotrexate formulation
    Patent number: 11129833
    Abstract: A liquid pharmaceutical composition comprises methotrexate free acid and a buffer, wherein the pH of the composition is in the range of 6.5 to 8.2. Processes for preparation of the liquid pharmaceutical composition are also described. The liquid pharmaceutical composition is useful in therapy.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: September 28, 2021
    Assignee: Therakind Ltd.
    Inventors: Michael Frodsham, Julie-Ann Penton
  • METHOTREXATE FORMULATION
    Publication number: 20170312281
    Abstract: A liquid pharmaceutical composition comprises methotrexate free acid and a buffer, wherein the pH of the composition is in the range of 6.5 to 8.2. Processes for preparation of the liquid pharmaceutical composition are also described. The liquid pharmaceutical composition is useful in therapy.
    Type: Application
    Filed: October 28, 2015
    Publication date: November 2, 2017
    Applicant: Therakind Ltd.
    Inventors: Michael FRODSHAM, Julie-Ann PENTON